Stian Knappskog

Stian Knappskog

UNVERIFIED PROFILE

Are you Stian Knappskog?   Register this Author

Register author
Stian Knappskog

Stian Knappskog

Publications by authors named "Stian Knappskog"

Are you Stian Knappskog?   Register this Author

82Publications

1664Reads

8Profile Views

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.

Int J Mol Sci 2019 Aug 29;20(17). Epub 2019 Aug 29.

Kristian Gerhard Jebsen Brain Tumour Research Centre, Department of Biomedicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20174235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747502PMC
August 2019

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.

Sci Rep 2019 Mar 27;9(1):5244. Epub 2019 Mar 27.

Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5020, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-41706-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437169PMC
March 2019

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Cell Stress 2019 Mar 22;3(4):118-135. Epub 2019 Mar 22.

K.G.Jebsen Center for Genome Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15698/cst2019.04.183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551830PMC
March 2019

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

Introducing nano-scale quantitative polymerase chain reaction.

Biochem Biophys Res Commun 2018 12 2;506(4):923-926. Epub 2018 Nov 2.

Department of Biomedicine, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2018.10.111DOI Listing
December 2018

BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?

Clin Epigenetics 2018 10 22;10(1):128. Epub 2018 Oct 22.

Department of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
https://clinicalepigeneticsjournal.biomedcentral.com/article
Publisher Site
http://dx.doi.org/10.1186/s13148-018-0566-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196557PMC
October 2018

High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.

BMC Cancer 2018 Jun 25;18(1):684. Epub 2018 Jun 25.

Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4591-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019524PMC
June 2018

APOBEC3A/B deletion polymorphism and cancer risk.

Carcinogenesis 2018 02;39(2):118-124

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgx131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862322PMC
February 2018

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.

Transl Oncol 2017 Oct 29;10(5):806-817. Epub 2017 Aug 29.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2017.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576977PMC
October 2017

Tumor cells interact with red blood cells via galectin-4 - a short report.

Cell Oncol (Dordr) 2017 Aug 14;40(4):401-409. Epub 2017 Mar 14.

Functional Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-017-0317-9DOI Listing
August 2017

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function.

Breast Cancer Res Treat 2017 May 17;163(1):177-190. Epub 2017 Feb 17.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4160-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387035PMC
May 2017

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines.

Cell Death Discov 2017 22;3:17026. Epub 2017 May 22.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cddiscovery.2017.26DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439126PMC
May 2017

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.

BMC Cancer 2017 02 3;17(1):97. Epub 2017 Feb 3.

Section of Oncology, Department of Clinical Science, University of Bergen, Haukeland University Hospiltal, Jonas Lies veg 87, 5021, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3094-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291962PMC
February 2017

Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers.

J Steroid Biochem Mol Biol 2017 01 22;165(Pt B):228-235. Epub 2016 Jun 22.

Department of Clinical Science, University of Bergen, 5021 Bergen, Norway; Hormone Laboratory, Haukeland University Hospital, 5021 Bergen, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2016.06.011DOI Listing
January 2017

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Neuro Oncol 2016 12 10;18(12):1644-1655. Epub 2016 Jun 10.

Department of Biomedicine, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., T.T., K.V., J.A.H., J.V.J., R.J., H.S.S., L.L., T.D., P.Ø.E., R.B., H.M.); KG Jebsen Brain Tumor Research Center, University of Bergen, Norway (E.E., G.V.R., K.M.T., O.K., K.V., J.A.H., J.V.J., T.D., P. Ø.E., S.P.N., R.B., H.M.); Department of Clinical Science, University of Bergen, Norway (S.K.); Department of Oncology, Haukeland University Hospital, Bergen, Norway (S.K.); Norlux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, Luxembourg (O.K., S.F., S.P.N., R.B.); Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK (A.S.); Department of Clinical Pharmacy, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Greifswald, Germany (S.F., C.A.R.); Department of Neurooncology, University Hospital Heidelberg, Germany (G.S., F.W.); Institute of Scientific Instruments, ASCR, Brno, Czech Republic (R.J.); Edinger-Intsitute, Goethe-University Medical School, Frankfurt am Main, Germany (P.N.H.); Department of Pathology, Haukeland University Hospital, Bergen, Norway (J.A.H., H.M.); Department of Clinical Neurosciences, University of Cambridge, UK (S.G.P., C.W.); Statistics and Computational Biology Laboratory, University of Cambridge, UK (I.S.); Neuro Clinic, Haukeland University Hospital, Bergen, Norway; Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, Germany (P.E.); Department of Systems Medicine, University of Rome «Tor Vergata», Rome, Italy (G.G.); INSERM U1029 - University of Bordeaux, Allée Geoffroy St. Hilaire, Pessac, France (T.D.); Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway (M.L.-J., P. Ø.E.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791772PMC
December 2016

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.

Sci Rep 2016 09 14;6:33153. Epub 2016 Sep 14.

Section of Oncology, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep33153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022009PMC
September 2016

Prevalence of the R95* germline mutation.

Hered Cancer Clin Pract 2016 27;14:19. Epub 2016 Sep 27.

Section of Oncology, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway ; Department of Oncology, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13053-016-0059-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039915PMC
September 2016

Promoter SNPs rs116896264 and rs73933062 form a distinct haplotype and are associated with galectin-4 overexpression in colorectal cancer.

Mutagenesis 2016 07 16;31(4):401-8. Epub 2015 Dec 16.

Division of Functional Genome Analysis, Deutsche Krebsforschungszentrum (DKFZ), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/mutage/gev086DOI Listing
July 2016

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer.

PLoS One 2015 6;10(8):e0134351. Epub 2015 Aug 6.

Hormone Laboratory, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0134351PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527840PMC
May 2016

MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.

Cancer Med 2015 Dec 16;4(12):1901-7. Epub 2015 Oct 16.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123711PMC
December 2015

Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon.

Int J Cancer 2015 Jul 10;137(1):96-103. Epub 2014 Dec 10.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.29358
Publisher Site
http://dx.doi.org/10.1002/ijc.29358DOI Listing
July 2015

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.

Acta Oncol 2014 Oct 9;53(10):1347-55. Epub 2014 Jun 9.

Section of Oncology, Department of Clinical Science, University of Bergen , Bergen , Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2014.922215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245178PMC
October 2014

Effects of SNP variants in the 17β-HSD2 and 17β-HSD7 genes and 17β-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue.

J Steroid Biochem Mol Biol 2014 Sep 18;143:192-8. Epub 2014 Feb 18.

Section of Oncology, Department of Clinical Science, University of Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2014.02.003DOI Listing
September 2014

MDM2 SNP309 and risk of endometrial cancer.

Tumour Biol 2014 Aug 26;35(8):7285-6. Epub 2014 Jun 26.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-014-2244-yDOI Listing
August 2014

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.

Science 2014 Aug;345(6196):1251343

Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1251343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380235PMC
August 2014

MDM2 SNP309 and risk of cervical cancer.

Tumour Biol 2014 Jul 17;35(7):6185-6. Epub 2014 Apr 17.

Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-014-1910-4DOI Listing
July 2014

Signatures of mutational processes in human cancer.

Nature 2013 Aug 14;500(7463):415-21. Epub 2013 Aug 14.

Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature12477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776390PMC
August 2013

MDM2 SNP309 and risk of endometrial cancer.

Pol J Pathol 2013 Apr;64(1):69-70

View Article

Download full-text PDF

Source
April 2013

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.

Biochim Biophys Acta 2013 Mar;1830(3):2790-7

Section of Oncology, Institute of Medicine, University of Bergen, Jonas Lies vei 65, N-5021 Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2012.12.004DOI Listing
March 2013

Chemosensitivity and p53; new tricks by an old dog.

Breast Cancer Res 2012 Nov 6;14(6):325. Epub 2012 Nov 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053121PMC
November 2012

Re: Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis.

Authors:
Stian Knappskog

Int J Urol 2012 Oct 30;19(10):966. Epub 2012 Jul 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-2042.2012.03108.xDOI Listing
October 2012

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers.

BMC Cancer 2012 Oct 5;12:454. Epub 2012 Oct 5.

Department of Medical Genetics, Oslo University Hospital – The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519699PMC
October 2012

Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk.

Transcription 2011 Sep-Oct;2(5):207-10

Section of Oncology, Institute of Medicine, University of Bergen; Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/trns.2.5.16813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265776PMC
June 2012

P53 and its molecular basis to chemoresistance in breast cancer.

Expert Opin Ther Targets 2012 Mar 8;16 Suppl 1:S23-30. Epub 2012 Feb 8.

Section of Oncology, Institute of Medicine, University of Bergen, 5020 Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2011.640322DOI Listing
March 2012

Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.

J Steroid Biochem Mol Biol 2012 Jan 16;128(1-2):69-75. Epub 2011 Sep 16.

Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2011.08.015DOI Listing
January 2012

Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.

Cancer 2011 Oct 31;117(20):4617-22. Epub 2011 Mar 31.

Department of Medical Sciences, Endocrine Oncology, Uppsala University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26124DOI Listing
October 2011

Exploring breast cancer estrogen disposition: the basis for endocrine manipulation.

Clin Cancer Res 2011 Aug 26;17(15):4948-58. Epub 2011 Jul 26.

Section of Oncology, Institute of Medicine, University of Bergen, and Department of Oncology, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0043DOI Listing
August 2011

Recent data on intratumor estrogens in breast cancer.

Steroids 2011 Jul 31;76(8):786-91. Epub 2011 Mar 31.

Section of Oncology, Institute of Medicine, University of Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.steroids.2011.02.040DOI Listing
July 2011

Alterations of the retinoblastoma gene in metastatic breast cancer.

Clin Exp Metastasis 2011 Mar 21;28(3):319-26. Epub 2011 Jan 21.

Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-011-9375-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040352PMC
March 2011

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.

Oncotarget 2011 Mar;2(3):251-8

Section of Oncology, Institute of Medicine, University of Bergen, 5020 Bergen, Norway.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260817PMC
http://dx.doi.org/10.18632/oncotarget.243DOI Listing
March 2011

New doctorial cancer research: germline genetic alterations affecting CDKN2A, MDM2, and CDKN1A in melanoma and breast cancer patients.

Authors:
Stian Knappskog

Crit Rev Oncog 2007 Dec;13(3):261-2; discussion 263

Section of Oncology, Institute of Medicine, University of Bergen.

View Article

Download full-text PDF

Source
December 2007

Mutations and polymorphisms of the p21B transcript in breast cancer.

Int J Cancer 2007 Aug;121(4):908-10

Department of Molecular Biology, University of Bergen, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22777DOI Listing
August 2007

A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.

Genes Chromosomes Cancer 2006 Dec;45(12):1155-63

Department of Medicine, Section of Oncology, Haukeland University Hospital, N-5021 Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20379DOI Listing
December 2006